Crocin I
CAS No. 94238-00-3
Crocin I( —— )
Catalog No. M19276 CAS No. 94238-00-3
Crocin I has anti atherosclerosis and hypolipidemic effects.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 83 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCrocin I
-
NoteResearch use only, not for human use.
-
Brief DescriptionCrocin I has anti atherosclerosis and hypolipidemic effects.
-
DescriptionCrocin I has anti atherosclerosis and hypolipidemic effects.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetFGFR
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number94238-00-3
-
Formula Weight976.97
-
Molecular FormulaC44H64O24
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 30 mg/mL
-
SMILESCC(=CC=CC=C(C)C=CC=C(C)C(=O)OC1C(C(C(C(O1)COC2C(C(C(C(O2)CO)O)O)O)O)O)O)C=CC=C(C)C(=O)OC3C(C(C(C(O3)COC4C(C(C(C(O4)CO)O)O)O)O)O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
FGFR2-IN-2
FGFR2-IN-2 is a specific FGFR2 inhibitor that inhibits FGFR1, FGFR2, and FGFR3, and can be used in the study of cancer and cardiovascular disease.
-
Dovitinib
A novel, multitargeted RTK inhibitor of class III, IV, and V RTKs.
-
Sunitinib Malate
Potent, ATP-competitive VEGFR, PDGFRβ and KIT inhibitor.
Cart
sales@molnova.com